The CANTATA-MSU Trial (CANagliflozin Treatment And Trial Analysis - Metformin and SUlphonylurea)

Completed · Phase 3 · Has a placebo group

Conditions studied: Diabetes Mellitus, Type 2

In brief

The purpose of this study is to evaluate the efficacy and safety of 2 different doses of canagliflozin compared with placebo in patients with type 2 diabetes mellitus who are receiving treatment with metformin and sulphonylurea and have inadequate glycemic (blood sugar) control.

Key facts

Study ID

NCT01106625

Run by

Janssen Research & Development, LLC

People needed

469

Starts

2010-05-01

Expected to finish

2012-04-01

Last updated by the study team

2013-06-20

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All patients must have a diagnosis of T2DM and be currently treated with metformin and sulphonylurea
• Patients in the study must have a HbA1c between >=7 and <=10.5%
• Patients must have a fasting plasma glucose (FPG) <270 mg/dL (15 mmol/L)

You may not qualify if…

• History of diabetic ketoacidosis, type 1 diabetes mellitus (T1DM), pancreas or beta cell transplantation, or diabetes secondary to pancreatitis or pancreatectomy, or a severe hypoglycemic episode within 6 months before screening

Where it is running

• Study site — Little Rock, Alaska, United States
• Study site — Phoenix, Arizona, United States
• Study site — Chino, California, United States
• Study site — Fair Oaks, California, United States
• Study site — Roseville, California, United States
• Study site — Wes Hills, California, United States
• Study site — Waterbury, Connecticut, United States
• Study site — Jacksonville, Florida, United States
• Study site — New Port Richey, Florida, United States
• Study site — Ocala, Florida, United States
• Study site — St. Petersburg, Florida, United States
• Study site — West Palm Beach, Florida, United States
• Study site — Augusta, Georgia, United States
• Study site — Roswell, Georgia, United States
• Study site — Chicago, Illinois, United States
• Study site — Lexington, Kentucky, United States
• Study site — New Orleans, Louisiana, United States
• Study site — Reisterstown, Maryland, United States
• Study site — Olive Branch, Mississippi, United States
• Study site — St Louis, Missouri, United States
• Study site — Westfield, New York, United States
• Study site — Greenville, North Carolina, United States
• Study site — Cincinnati, Ohio, United States
• Study site — Tulsa, Oklahoma, United States
• Study site — Huntsville, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.